In a significant move to enhance its global presence, Hyderabad-based Natco Pharma has announced plans to acquire a 36% equity stake in South Africa’s Adcock Ingram for approximately Rs. 1,887 crore (USD 226 million). This investment, structured through a combination of share purchases and open offers, underscores Natco’s commitment to expanding into high-growth emerging markets. The acquisition will strengthen Natco’s footprint across the African continent, diversify its revenue streams, and align with its long-term strategy of scaling operations beyond India.